Table 1 Demographic characteristics and baseline isokinetic assessment results of the study groups
Isotretinoin group (n = 25) | Control group (n = 30) | p value | |
|---|---|---|---|
Sex | |||
Female (n) (%) | 19 (74) | 23 (76.6) | 0.93 |
Male (n) (%) | 6 (24) | 7 (23.4) | |
Age (median) (min-max) | 19 (18–27) | 19 (18–28) | 0.90 |
BMI (mean ± SD) | 21.5 ± 2.8 | 22.6 ± 2.5 | 0.15 |
CPK IU/l (mean ± SD) | 82.6 ± 39.1 | 84.7 ± 30.8 | 0.82 |
Mean concentric quadriceps PT | |||
(Nm) (SD) | |||
60°/s AV | 111.2 ± 33.5 | 105.1 ± 39.8 | 0.55 |
120°s AV | 77.0 ± 26.1 | 76.7 ± 29.0 | 0.97 |
Mean concentric hamstring PT | |||
(Nm) (SD) | |||
60°/s AV | 66.1 ± 15.8 | 62.3 ± 15.7 | 0.39 |
120°/s AV | 54.0 ± 12.2 | 53.2 ± 15.0 | 0.81 |